|
| |
GABA-B-R3
| Symbol: | GABA-B-R3 | | Name(s): | metabotropic GABA-B receptor subtype 3 | | Type: | protein-coding | | Organism: | Drosophila melanogaster | | Synonyms: | CG3022, D-GABA[[B]]R3, D-Gaba3, GB3, anon-WO0170980.13, anon-WO0170980.14 | | Links: |
Pubmed,
Entrez Gene,
Map Viewer.
|
Press Releases on GABA-B-R3:
|
 |
| Reportlinker Adds Ion Channel Modulator Pipelines: Targets and Agents in Development |
26th October, 2009 |
Reportlinker |
-- Prospects for ion channel modulators and commercial successes to date--
Pipeline activities, expert views, and survey results
Ion Channel Modulator Pipelines: Targets
|
| Henry Ford West Bloomfield Hospital Launches Gene Therapy Study for Parkinson's Disease |
6th October, 2009 |
Henry Ford Health System |
WEST BLOOMFIELD, Mich., Oct. 6 /PRNewswire/ -- Henry Ford West Bloomfield Hospital is embarking on a research study for advanced Parkinson's disease using a state-of-the-art
|
| Reportlinker Adds Therapeutics for Memory and Cognition Disorders Report |
3rd September, 2009 |
Reportlinker |
-- Analyzes the market outlook, trends, and challenges.
Chapter-1: SUMMARY
SUMMARY TABLE WORLDWIDE POTENTIAL MARKET FOR MEMORY/COGNITION
|
| Marinus Pharmaceuticals Adds Two Life Sciences Veterans to its Board of Directors |
29th July, 2009 |
Marinus Pharmaceuticals, Inc. |
BRANFORD, Conn., July 29 /PRNewswire/ -- Marinus Pharmaceuticals, Inc. a developer of drugs to treat serious neurological and psychiatric disorders, today announced the appointment of
|
| Jazz Pharmaceuticals and UCB Announce Second Phase III Study of Sodium Oxybate in Patients With Fibromyalgia Meets Primary Endpoints |
24th June, 2009 |
Jazz Pharmaceuticals, Inc. |
Preliminary top-line results of second Phase III study show highly significant decreases in pain and fatigue and improved daily function in fibromyalgia patients and confirm results from the
|
GABA-B-R3 results (if any) from reagent suppliers | 
|
Artemin Antibody
B=Bovine; Ca=Cat; Ch=Chicken; GP=Guinea Pig; H=Human; M=Mouse; P=Porcine; ... VEGF R3 (Flt-4); |; Wnt1 Inducible Signaling Pathway Protein 3/WISP3 ...
http://www.neuromics.com/ittrium/visit/A1x66x1y1x6217x1x96y1...
|
 |
Search for Products - R&D Systems
Tyrosine Hydroxylase (3). NMDA R, NR2B Subunit (3). Akt (3). HGF R (3) ... PTEN (1). Rad17 (1). ErbB3 (1). Flt-3 (1). GABA B R2 (1). GSK-3 alpha/beta (1) ...
http://www.rndsystems.com/product_results.aspx?c=6&k=phospho...
|
 |
BIOMOL International - Antibodies
SA-233 · Anti-DCR1 (TRID, TRAIL-R3, LIT), • Death Ligands and Receptors .... SA- 530 · Anti-GABAB Receptor R2 Subunit (pS892), • GABA Receptors ...
http://www.biomol.com/?pageId=36&search=&mode=product&lastSo...
|
 |
de novo
FGF R3 (IIIc) . . . . . . . . . . . . . . . . .human . ..... GABA-BR2 . . . . . . . . . . . . . . . . . . .rat . . . . . . . . . . . . . . . . . . .AF1188 .
...... tion, lineage-negative cells were stained B) for expression of ...
http://www.rndsystems.com/DAM_public/5316.pdf...
|
 |
Ligands innen 12.6.-115%
BT-ES-500-M GABA B Receptor, Human lyophilized membrane. 55.9 and 83.9 pmol/mg receptor ...... (2S,2'R,3'R)-2-(1'-3H,2',3'-. 1 mCi/ml. 0.370-0.925 TBq/mmol ...
http://www.biotrend.com/download/LL06115.pdf...
|
 |
R&D Systems NEUROSCIENCE REFERENCE GUIDE
VEGF R3/Flt-4. H M. H M. H M. H M. H M. Key: H Human M Mouse R Rat B Bovine Ca Canine ...... H M R B. GABA-A-Rb , , 3. H M R. GABA-A-Rg. H M R B. GABA-B-R ...
http://www.rndsystems.com/DAM_public/5952.pdf...
|
 |
ChemCruz™ Biochemicals
sc-202011, Selective GABAB antagonist, more potent than saclofen ...... (R)-3- Chloro-1-phenyl-1-[2-methyl-4-[(tert-butoxycarbonyl)oxy]phenoxy]propane ...
http://www.scbt.com/chapter_chemicals.html...
|
 |
Search Bioportfolio and other Life Science Sites for GABA-B-R3,
or search for GABA-B-R3 on BioPortfolio's antibody search engine.
This page has been viewed 74 times
Resources from the NCBI used on this page, NCBI's standard disclaimer applies.
|
